Bartter-like syndrome (BLS) is a constellation of biochemical abnormalities which include metabolic alkalosis, hypokalemia, hypocalcemia, hypomagnesemia with normal kidney function. BLS is a very rare syndrome and can be induced by certain diseases, antibiotics, diuretics, and antineoplastic drugs. Colistin is a polymicrobial bactericidal drug and currently re-emerged as the only salvation therapy against multidrug resistant bacilli especially in critically ill patients at intensive care units. Only an anecdotal case report of colistin-induced Bartter-like syndrome has been reported. We here report a case series of four critically ill patients who were on treatment with colistin and presented with serious metabolic disturbances.
Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14. DOI: 10.1186/2110-5820-1-14.
Lee BH, Cho Hy, Lee H, Han KH, Kang HG, Ha IS, et al. Genetic basis of Barter syndrome in Korea. Nehrol Dial Transplant 2012;27(4); 1516–1521. DOI: 10.1093/ndt/gfr475.
Holmes AM, Hesling CM, Wilson TM. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis. Q J Med 1970;39:299–315. PMID: 5449594.
Kelnar CJ, Taor WS, Reynolds DJ, Smith DR, Slavin BM, Brook CG. Hypomagnesaemic hypocalcaemia with hypokalemia caused by treatment with high dose gentamicin. Arch Dis Child 1978;53(10): 817–820. DOI: 10.1136/adc.53.10.817.
Keating MJ, Sethi MR, Bodey GP, Samaan NA. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer 1977;39(4):1410–1414. DOI: 10.1002/1097-0142(197704)39:4<1410::aid-cncr2820390409> 3.0.co;2-d.
Alexandridis G, Liberopoulos E, Elisaf M. Aminoglycoside-induced reversible tubular dysfunction. Pharmacology 2003;67(3):118–120. DOI: 10.1159/000067797.
Chrispal A, Boorugu H, Prabhakar AT, Moses V. Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia. J Postgrad Med 2009;55(3): 208–210. DOI: 10.4103/0022-3859.57407.
Chou CL, Hwang Y, Chau T, Lin SH. Acquired Bartter-like syndrome associated with gentamicin administration. Am J Med Sci 2005;329(3):144–149. DOI: 10.1097/00000441-200503000-00007.
Cakir U, Alan S, Zeybek C, Erdeve O, Atasay B, Yalcinkaya F, et al. Acquired Bartter-like syndrome associated with colistin use in a preterm infant. Ren Fail 2013;35(3):411–413. DOI:10.3109/0886022X.2012.761084.
Eldin TK, Tosone G, Capuano A, Orlando R. Reversible hypokalemia and Bartter-like syndrome during prolonged systemic therapy with colistimethate sodium in an adult patient. Drug Saf Case Rep 2017;4(1):10. DOI: 10.1007/s40800-017-0052-1.
Choks T, Shah S. Prolonged intravenous colistin use associated with acquired Bartter-like syndrome in an adult patient: a case report. EMJ Nephrol 2018;6(1):102–105.
Ruiz Acosta AG, Acuna Diaz AV, Labrano Elias MME, Valenzuela Vazquez CA. Pseudo Bartter syndrome associated with intravenous infusion of colistin. Rev Virtual Soc Parag Med Int 2018;5(2): 79–84. DOI: 10.18004/rvspmi/2312-3893/2018.05(02)79-084.
Desfleurs E, Wittner M, Simeone S, Pajaud S, Moine G, Rajerison R, et al. Calcium-sensing receptor: regulation of electrolyte transport in the thick ascending limb of Henle's loop. Kidney Blood Press Res 1998;21(6):401–412. DOI: 10.1159/000025892.
Breazu CM, Bartos A, Bartos D. Bartter and Gitelman syndromes. In: Fluid and electrolyte disorders 2018. DOI: 10.5772/intechopen.81745.